AI Article Synopsis
- - Cardiovascular health has significantly deteriorated due to SARS-CoV-2, the virus causing the COVID-19 pandemic, particularly affecting people with preexisting heart conditions.
- - COVID-19 can lead to various serious heart-related issues, including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism, either directly or indirectly.
- - Understanding the renin-angiotensin-aldosterone system (RAAS) is crucial for assessing heart-related risks and effects of COVID-19 treatments, highlighting the need for awareness of cardiovascular symptoms in patients.
Article Abstract
Cardiovascular wellbeing has been dramatically affected by severe acute respiratory syndrome coronavirus (SARS-CoV-2), the reason for the coronavirus disease pandemic 2019 (COVID-19) pandemic. There is a greater risk of morbidity and death in individuals with preexisting heart diseases. Clinical syndromes of the acute coronary syndrome, acute myocardial injury, myocarditis, arrhythmias, heart failure, and venous thromboembolism can, directly and indirectly, affect the heart. There may also be adverse heart effects of specific therapeutics under review for COVID-19. The renin-angiotensin-aldosterone system (RAAS) mechanism in virus replication makes it essential to understand the consequences of the system-modulating medications. For optimum patient care, detailed knowledge of specific cardiovascular symptoms of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is necessary.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438797 | PMC |
| http://dx.doi.org/10.1016/j.cpcardiol.2021.100981 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!